Literature DB >> 2341370

Physicochemical and biological comparison of recombinant human erythropoietin with human urinary erythropoietin.

N Imai1, A Kawamura, M Higuchi, M Oh-eda, T Orita, T Kawaguchi, N Ochi.   

Abstract

Physicochemical and biological properties of recombinant human erythropoietin (rhEPO) were compared with human urinary erythropoietin (uEPO). uEPO and rhEPO were purified to apparent homogeneity from the urine of patients with aplastic anemia and from the conditioned medium of Chinese hamster ovary (CHO) cells transfected with a cDNA clone for human EPO, respectively. The microheterogeneous nature of both factors, observed on isoelectric focusing, is derived from the difference of the number of terminal sialic acid residues bound to the carbohydrate chains of the EPO molecule. The primary structure of rhEPO, consisting of 165 amino acid residues, was determined, and the C-terminal arginine predicted from the cDNA sequence was confirmed to be missing, as described previously (Recny et al. (1987) J. Biol. Chem. 262, 17156). Three N-glycosylation and one O-glycosylation sites of both factors were determined as Asn24, Asn38, and Asn83 and Ser126, respectively. Two disulfide linkages are located between Cys7 and Cys161, and between Cys29 and Cys33, in both EPOs. Hematogenic potencies of rhEPO and uEPO compared in normal and in partially nephrectomized rats were approximately the same. Both factors also stimulated the colony formation of CFU-E, BFU-E, and CFU-Meg in a dose-dependent manner. From these results, it is concluded that rhEPO produced in CHO cells transfected with cDNA clone for human EPO is indistinguishable from uEPO physicochemically and biologically, and is valuable for further research and for clinical use.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341370     DOI: 10.1093/oxfordjournals.jbchem.a123050

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  15 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

Review 2.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

3.  Charting a course for erythropoietin in traumatic brain injury.

Authors:  Kenneth Maiese
Journal:  J Transl Sci       Date:  2016-03-26

Review 4.  Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

5.  Pharmacokinetic and pharmacological profiles of free and liposomal recombinant human erythropoietin after intravenous and subcutaneous administrations in rats.

Authors:  H Moriya; Y Maitani; N Shimoda; K Takayama; T Nagai
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

6.  Immunocytochemical demonstration of erythropoietin in hypoxic human hepatoma cultures.

Authors:  C Herkens; M Wolff; J Fandrey; F Schuler; W Jelkmann
Journal:  Histochemistry       Date:  1993-10

Review 7.  Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit.

Authors:  Jules A A C Heuberger; Joost M Cohen Tervaert; Femke M L Schepers; Adriaan D B Vliegenthart; Joris I Rotmans; Johannes M A Daniels; Jacobus Burggraaf; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

8.  Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous production.

Authors:  N Hayashi; H Kinoshita; E Yukawa; S Higuchi
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

Review 9.  Erythropoietin and oxidative stress.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Curr Neurovasc Res       Date:  2008-05       Impact factor: 1.990

10.  Expression and purification of recombinant human angiopoietin-1 produced in Chinese hamster ovary cells.

Authors:  Su-Jeong Hwang; Hak-Zoo Kim; Gou Young Koh; Gyun Min Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-07-10       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.